Go to deals
Healthcare

Maria Beroendecentrum AB has been acquired by Capio AB

Maria Beroendecentrum AB, healthcare provider operating a drying-out clinic, has been acquired by Capio AB. Financial details have not been disclosed.

Capio has won the procurement to operate addiction treatment care within the county council of Stockholm for the next five years. After this acquisition, the new company will have almost 200 employees.

“We are very happy with the notification from the city council of Stockholm (SLL) implying that we will operate and manage the important addiction treatment program within the region of Stockholm. With locally integrated care centers within close reach of the patients, we will do our best to efficiently help and cure patients with drug and addiction habits,” said Åke Strandberg, Business Area Manager of Specialist Clinics Operations in Sweden.

Oaklins' team in Sweden advised the seller in this transaction.

Parties

Talk to the deal team

Anders Ingler

Senior Advisor
Stockholm, Sweden
Oaklins Sweden

Related deals

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Healthcare

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Learn more
Afric Phar has been acquired by Pharma Capital
Healthcare

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

Learn more
Xiel Limited has been acquired by MIS Healthcare
Private Equity | Healthcare

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Learn more